This is a list of all Pulmonology related medical scores and algorithms with their corresponding calculator/app.
Determines the predicted maximum speed of expiration based on age, gender and height and compares it to the measured PEFR.
Estimates the VO2 max aerobic capacity through the four most common methods from resting heart rate to activity tests.
Determines vascular resistance based on pressure difference and blood flow in pulmonary circulation.
Determines the target tidal volume by height and depth of ETT placement.
Determines MPAP which is used to check for pulmonary hypertension.
Determines the expected distance to be walked when evaluating the patient’s functional status in cardiopulmonary conditions.
Predicts postoperative risk of PRF in elderly male patients based on available clinical data and type of surgery.
Determines the ratio of the forced expiratory volume in the first second to the forced vital capacity of the lungs.
Determines the mean airway pressure applied during positive-pressure mechanical ventilation.
Determines the total volume of gas in or out of the lung per minute based on tidal volume and respiratory rate.
Determines the total volume of fresh air entering the alveoli per minute.
Predicts risk of pulmonary complications after surgery to help guide clinician decision making.
Uses lung volumes to determine vital, inspiratory and functional residual capacity.
Provides an alternative way to estimate vital capacity based on gender, age and height when inspiratory, tidal and expiratory volumes can’t be measured.
Helps with the differential diagnosis between pleural effusions of exudate and transudate type.
Determines the most commonly tested respiratory parameters and capacities based on easily obtained data and volumes.
Determines the partial pressure of alveolar oxygen that reflects the ventilation process.
Determines arterial oxygen based on haemoglobin, O2 saturation and arterial pressure.
Assesses if successful extubation is possible in intubated patients breathing spontaneously who meet other clinical criteria.
Determines the resistance of the respiratory tract to airflow during inhalation and exhalation.
Stratifies pulmonary embolism (PE) mortality risk based on clinical data.
Determines the air that remains in the lungs after maximal expiration.
Screens for obstructive sleep apnea based on symptoms and OSA risk factors.
Predicts outcomes in patients with acute lung injury and acute respiratory distress syndrome, and helps determine need for ECMO.
Diagnoses community acquired pneumonia and stratifies mortality risk.
Evaluates cases of severe acute respiratory failure to check the need for extracorporeal membrane oxygenation (EMCO) instead of ventilation.
Assesses the severity of apnea, therefore can help clinicians with the diagnosis of obstructive sleep apnea.
Corrects the pulmonary result for haemoglobin in patients with anemia.
Determines the amount of oxygen delivered to the capillaries per minute based on arterial oxygen content and cardiac output.
Predicts likelihood of cancer of the evaluated lung nodules in the next 2 to 4 years.
Estimates the pulmonary VC based on tidal, inspiratory and expiratory reserve volumes.
Determines the PaO2/FiO2 ratio which assesses lung function in acute respiratory distress.
Helps predict risk of mechanical ventilation for longer than 48 hours or risk of reintubation within 30 days from surgery.
Helps diagnose streptococcal pharyingitis in children and adults based on clinical data.
Predicts survival in patients with chronic obstructive pulmonary disease (COPD).
Stratifies pulmonary embolism risk before invasive testing or CT angiography take place.
BSI is a clinical predictive tool that identifies patients at risk of future mortality, hospitalization, and exacerbations.
Helps diagnose hypoxemia and its cause based on the difference between alveolar and arterial oxygen concentration.
Diagnoses and evaluates ARDS severity based on required criteria and risk factors.
Estimates FRC based on expiratory reserve and residual volume.
Stratifies patients according to their chances of being diagnosed with ventilator associated pneumonia.
Differentiates between patients at low or high risk of pulmonary embolism.
Estimates the IC based on the inspiratory reserve and the tidal volume.
Consists of the original, revised and simplified Geneva risk predictors for pulmonary embolism (PE).
Determines the amount of physiological dead space in a person's lungs to evaluate extent of wasted ventilation.
Helps diagnose FES based on Schonfeld rule and Gurd's and Wilson's criteria.
Evaluates the severity of dyspnea in patients who suffer from chronic obstructive pulmonary disease.
Helps screen patients at increased risk of postoperative pneumonia based on available clinical data.
Determines bleeding risk in patients diagnosed with pulmonary embolism before anticoagulation therapy is initiated.
Evaluates risk of asthma diagnosis in the future for children aged three or less suffering from recurrent wheezing.
Stratifies patients with community acquired pneumonia and offers 30-day mortality prediction.
Evaluates disease severity and mortality risks associated with non-cystic fibrosis bronchiectasis based on exacerbations and clinical factors.
Prognoses likelihood of future acute asthma in pediatric patients.
Stratifies pulmonary disease based on FEV1, FVC results and dyspnea severity.
Evaluates respiratory health and whether the patient suffers from symptoms and signs of asthma.
Predicts 2-year survival rates for patients with small cell lung cancer (SCLC) based on Karnofsky score and lab tests.
Stratifies bronchiectasis severity based on CT radiological findings in patients with cystic fibrosis.
Identifies patients with CAP at risk of ICU admission, intensive respiratory or vasopressor support (IRVS).
Evaluates the extent of bronchiectasis through site, type and extent on CT imagistic.
Predicts 30-day mortality risk in patients with active cancer diagnosed with PE.
DRIP predicts likelihood of antibiotic resistance in patients with bacterial pneumonia.
Assesses cystic fibrosis severity based on chest radiographic findings.
Assesses bronchiectasis severity based on bronchial dilatation and number of segments affected by emphysema.
